India, Sept. 9 -- Biotech and medical device stocks saw notable moves Wednesday, led by Opus Genetics, which surged more than 27% following positive clinical data. Quantum BioPharma gained after receiving FDA clearance for a Phase 2 MS trial, while Pulse Biosciences rallied more than 14%. Decoy Therapeutics and ONWARD Medical also traded higher.
Read on.
Opus Genetics, Inc. (IRD) announced positive 3- and 6-month data from Cohort 1 of its Phase 1/2 BIRD-1 trial evaluating OPGx-BEST1 in patients with BEST1-related retinal diseases, including BVMD and ARB. All five participants showed clinically meaningful visual-function improvements, while four demonstrated structural improvements. No serious adverse events or dose-limiting toxicities wer...